Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factor Va (FVa) is the activated form of coagulation factor V and a crucial cofactor in the blood coagulation cascade. It forms a complex with factor Xa (FXa) on phospholipid surfaces to efficiently convert prothrombin to thrombin, a key step in hemostasis. Its activity is regulated by activated protein C (APC). Deficiency leads to bleeding disorders, while resistance to APC-mediated inactivation (e.g., Factor V Leiden mutation) increases the risk of thrombosis.
FVa acts as a cofactor for FXa in the prothrombinase complex, accelerating the conversion of prothrombin to thrombin. Drugs targeting FVa can inhibit its activity or regulate its activation/inactivation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor Va (FVa).